Early Detection and Diagnosis

You have full text access to this OnlineOpen article

A blood-based biomarker panel for stratifying current risk for colorectal cancer

  1. Kenneth Wayne Marshall1,
  2. Steve Mohr1,
  3. Faysal El Khettabi1,
  4. Nadejda Nossova1,
  5. Samuel Chao1,
  6. Weisheng Bao1,
  7. Jun Ma1,
  8. Xiao-Jun Li1,
  9. Choong-Chin Liew1,2,†,*

Article first published online: 30 SEP 2009

DOI: 10.1002/ijc.24910

Issue

International Journal of Cancer

International Journal of Cancer

Volume 126, Issue 5, pages 1177–1186, 1 March 2010

Additional Information

How to Cite

Marshall, K. W., Mohr, S., Khettabi, F. E., Nossova, N., Chao, S., Bao, W., Ma, J., Li, X.-J. and Liew, C.-C. (2010), A blood-based biomarker panel for stratifying current risk for colorectal cancer. Int. J. Cancer, 126: 1177–1186. doi: 10.1002/ijc.24910

Author Information

  1. 1

    GeneNews Ltd., Richmond Hill, Ontario, Canada

  2. 2

    Brigham and Women's Hospital, Harvard Medical School, Boston, MA

  1. †

    Fax: +905-739-2031

*GeneNews Ltd., 2 East Beaver Creek Road, Building 2, Richmond Hill, Ontario L4B 2N3, Canada

Publication History

  1. Issue published online: 27 DEC 2009
  2. Article first published online: 30 SEP 2009
  3. Accepted manuscript online: 30 SEP 2009 12:00AM EST
  4. Manuscript Accepted: 8 SEP 2009
  5. Manuscript Received: 31 JUL 2009

Funded by

  • GeneNews Ltd., Richmond Hill

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (616K)

References

  • 1
    American Cancer Society. Detailed guide: colon and rectum cancer. Atlanta: American Cancer Society, 2008. Available at: http://www.cancer.org/docroot/CRI/CRI_2_3x.asp?dt=10. Accessed March 23, 2009.
  • 2
    Cancer Research UK. Bowel (colorectal cancer). Key facts on bowel cancer, 2008. Available at: http://info.cancerresearchuk.org/cancerstats/types/bowel/. Accessed March 23, 2009.
  • 3
    Stryker SJ, Wolff BG, Culp CE, Libbe SD, Ilstrup DM, MacCarty RL. Natural history of untreated colonic polyps. Gastroenterol 1987; 92: 1009–13.
  • 4
    O'Connell JB, Maggard M, Ko CY. Colon cancer survival rates with the new American Joint Committee on cancer sixth edition staging. J NCI 2004; 96: 1420–5.
  • 5
    US Preventive Services Task Force. Screening for colorectal cancer: recommendations and rationale. Ann Intern Med 2002; 137: 129–31.
  • 6
    Canadian Task Force on Preventive Health Care. Colorectal cancer screening: recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ 2001; 165: 206–8.
  • 7
    Robb KA, Miles A, Campbell J, Evans P, Wardle J. Can cancer risk information raise awareness without increasing anxiety? A randomized trial. Prev Med 2006; 43: 187–90.
  • 8
    Schwartz LM, Woloshin S, Fowler FJ, Welch HG. Enthusiasm for cancer screening in the United States. JAMA 2004; 291: 71–8.
  • 9
    US Department of Health and Human Services Centers for Disease Control and Prevention. Colorectal cancer test use among persons aged greater than or equal to 50 years—United States, 2001. MMWR 2003; 52: 193–6.
  • 10
    Zarychanski R, Chen Y, Bernstein CN, Hebert PC. Frequency of colorectal screening and the impact of family physicians on screening behaviour. CMAJ 2007; 177: 593–97.
  • 11
    American Cancer Society. Cancer prevention and early detection facts and figures. Atlanta: American Cancer Society, 2007.
  • 12
    Klabunde CN, Lanier D, Breslau ES, Zapka JG, Fletcher RH, Ransohoff DF, Winawer SJ. Improving colorectal cancer screening in primary care practice: innovative strategies and future directions. J Gen Int Med 2007; 22: 1195–205.
  • 13
    Levin TR, Zhao W, Conell C, Seeff LC, Manninen DL, Shapiro JA, Schulman J. Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med 2006; 145: 880–6.
  • 14
    Liew CC, Ma J, Tang HC, Zheng R, Dempsey AA. Peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med 2006; 147: 126–32.
  • 15
    Burczynski ME. Transcriptional profiling of peripheral blood in oncology. In: BurczynskiME, RockettJC, eds. Surrogate tissue analysis: genomic, proteomic and metabolomic approaches. Boca Raton, FL: Taylor and Francis, 2006. 47–63.
  • 16
    Han M, Liew CT, Zhang HW, Chao S, Zheng R, Yip KT, Song ZY, Li HM, Geng XP, Zhu LX, Lin JJ, Marshall KW, et al. Novel, blood-based five-gene panel biomarker set for the detection of colorectal cancer. Clin Cancer Res 2008; 14: 455–60.
  • 17
    Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME; Colorectal Cancer Study Group. Faecal DNA versus faecal occult blood for colorectal-cancer screening in an average-risk population. New Engl J Med 2004; 351: 2704–14.
  • 18
    Pharoah PDP, Antoniou AC, Easton DF, Ponder BAJ. Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med 2008; 358: 2796–803.
  • 19
    Tibshirani R, A simple method for assessing sample sizes in microarray experiments. BMC Bioinformatics 2006; 7: 106.
  • 20
    Rozen S, Skaletsky H. Primer 3 on the WWW for general users and for biologist programmers. In: KrawetzS, MisenerS, eds. Bioinformatics methods and protocols: methods in molecular biology. Totowa, NJ: Humana Press, 2000: 365–86.
  • 21
    Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402–8.
  • 22
    Gordon GJ, Jensen RV, Hsiao LL, Gullans SR, Blumenstock JE, Richards WG, Jaklitsch MT, Sugarbaker DJ, Bueno R. Using gene expression ratios to predict outcome among patients with mesothelioma. J NCI 2003; 95: 598–605.
  • 23
    Hastie T, Tibshirani R, Friedman J. The elements of statistical learning: data mining, inference, and prediction. New York: Springer-Verlag, 2001.
  • 24
    Mann HB, Whitney DR. On a test of whether one of two random variables is stochastically larger than the other. Ann Math Stat 1947; 18: 50–60.
  • 25
    Duda RO, Hart PE, Stork DG. Pattern classification, 2nd edn. New York: Wiley, 2000.
  • 26
    Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika 1965; 52: 591–611.
  • 27
    Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 2001; 96: 2992–3003.
  • 28
    Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer 2006; 42: 216–27.
  • 29
    Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, Dash C, Giardiello FM, Glick S, Levin TR, Pickhardt P, Rex DK, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer and the American College of Radiology. CA cancer. J Clin 2008; 58: 130–60.
  • 30
    Mohr S, Liew CC. The peripheral blood transcriptome: new insights into disease and risk assessment. Trends Mol Med 2007; 13: 422–32.
  • 31
    Park JE, Lee DH, Lee JA, Park SG, Kim NS, Park BC, Cho S. Annexin A3 is a potential angiogenic mediator. Biochem Biophys Res Comm 2005; 337: 1283–7.
  • 32
    García-Tuñón I, Ricote M, Ruiz A, Fraile B, Paniagua R, Royuela M Interleukin-2 and its receptor complex (alpha, beta and gamma chains) in in situ and infiltrative human breast cancer: an immunohistochemical comparative study. Br Can Res 2004; 6: R1–6.
  • 33
    Vijan S, Inadomi J, Hayward RA, Hofer TP, Fendrick AM. Projections of demand and capacity for colonoscopy related to increasing rates of colorectal cancer screening in the United States. Aliment Pharmacol Ther 2004; 20: 507–15.
View Full Article (HTML) Get PDF (616K)